LIVE SESSION BRIEF Drug Manufacturers - Specialty & Generic $19M Cap Quant: HOLD

AYTU BioPharma, Inc. (AYTU) — Live Session & Technical Brief

Updated Nov 16, 2026 2:29 PM ET · Prev Close $1.78

Pro Workspace
Last Session Price
$1.81 +1.69%
+$0.03 vs $1.78 prior close
Intraday Range
$1.75 – $1.87
Open $1.77
Relative Volume
0.89x Avg
22,736 sh
52-Week Range
$1.75 – $3.06
Benchmark Alpha
+3.58% vs SPY
+4.11% vs QQQ
20-Session Trend -10.0%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (+1.69%) in Drug Manufacturers - Specialty & Generic

AYTU BioPharma, Inc. (AYTU) is trading within a tight intraday band at $1.81 (+1.69%, 0.89x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AYTU is outperforming the S&P 500 by +3.58%. 14-day RSI stands at 37.7, keeping momentum in a bearish regime.

NEWS 70% Weight
Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026

Denver, Co Access Newswire November 10, 2026 the Company or Aytu Nasdaq AYTU , a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($1.81) trades relative to 20-day SMA ($1.89) and 50-day SMA ($2.00).

Volume Confirmation
MODERATE VOLUME (0.89x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

AYTU outperforming the S&P 500 by +3.58%
AYTU Session
+1.69%
$1.81
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: +3.58% Alpha vs QQQ: +4.11% Alpha vs XLV: +2.07%

Recent AYTU Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$1.74
Short-term support band
Upper Bound
$1.88
Short-term resistance band
Key Inflection Level
$1.89 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $1.89 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (AYTU)

BEARISH MA TREND
RSI (14)
37.7
Bearish
20-Day SMA
$1.89
Below 20d
50-Day SMA
$2.00
Below 50d
MACD Signal
Bearish
MACD -0.07
ADX (14)
22.2
Moderate trend
10d Momentum
-0.13
Soft 10-day momentum

Retail & Crowd Sentiment

Bearish
24h Messages
0
7d avg 0.3
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

A bullish trader on StockTwits highlights $AYTU's potential in the anti-depressant market through their new product Exxua, which is gaining traction despite the company's past issues.

Reddit communities: 1 comment (Bearish)

About AYTU BioPharma, Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease …

Sector
Healthcare
Market Cap
$19M
Forward P/E
3.7x
Employees
83

Get Instant AYTU Catalyst Alerts

Receive an email alert when AYTU triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

AYTU Session & Catalyst FAQ

Why is AYTU stock trading near flat today?

AYTU BioPharma, Inc. (AYTU) is trading within a tight intraday band at $1.81 (+1.69%, 0.89x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AYTU is outperforming the S&P 500 by +3.58%. 14-day RSI stands at 37.7, keeping momentum in a bearish regime.

Is AYTU stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.89x relative volume (moderate participation). Our multi-factor model currently rates AYTU as HOLD. Review full valuation, quality, and timing signals on the AYTU Buy or Sell Decision Brief →

What is AYTU's intrinsic value and expected trading range?

At $1.81, AYTU's modeled 1-to-3 session range is $1.74 – $1.88, with a key inflection level at $1.89 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the AYTU Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for AYTU?

RSI at 37.7 reflects soft below-midline momentum. AYTU trades at $1.81 relative to its 20-day SMA ($1.89) and 50-day SMA ($2.00), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs